Literature DB >> 22948773

Erectile dysfunction as a cardiovascular risk factor in patients with diabetes.

Giorgio Gandaglia1, Andrea Salonia, Niccolò Passoni, Piero Montorsi, Alberto Briganti, Francesco Montorsi.   

Abstract

Erectile dysfunction (ED) is a highly prevalent disorder among patients with diabetes mellitus (DM). In most cases, ED is considered a vascular disease and its development is significantly related to the exposure to CVD risk factors. In this context, ED and coronary artery disease (CAD) have been proposed as different manifestations of the same systemic disease; in nondiabetic patients, ED has progressively emerged as an important sentinel marker of the subsequent onset of CVD events. The aim of this review was to evaluate the association between ED and CAD in diabetic patients and to evaluate the role of ED as an independent CVD risk factor in these patients. Three large prospective studies confirmed that ED is a powerful predictor of CAD and cardiac mortality in patients with DM. Overall, diabetic patients with ED had roughly 1.4-fold higher risk of CAD as compared with those without ED. Interestingly, in diabetic patients, CAD is often silent and CAD screening according to the current guidelines can miss up to 40 % patients with occult myocardial perfusion abnormalities. Indeed, patients with ED have higher risk of silent myocardial ischemia compared to those without ED, and when ED is added to the risk factors, it can even improve the sensitivity of screening for asymptomatic CAD. Therefore, ED should be considered an independent CVD risk factor, and it could improve the identification of diabetic patients suitable for screening, leading to an early detection of CAD, and thus potentially enhancing the therapeutic effectiveness.

Entities:  

Mesh:

Year:  2012        PMID: 22948773     DOI: 10.1007/s12020-012-9780-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  79 in total

1.  Could a rural lifestyle decrease the prevalence of erectile dysfunction?

Authors:  Joaquim De Almeida Claro; Oskar Grau Kaufmann; Gustavo Alarcon; Wilson Aguiar; Archimedes Nadozza; Valdemar Ortiz; Miguel Srougi
Journal:  BJU Int       Date:  2006-10-11       Impact factor: 5.588

2.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Definitions/epidemiology/risk factors for sexual dysfunction.

Authors:  Ronald W Lewis; Kerstin S Fugl-Meyer; Giovanni Corona; Richard D Hayes; Edward O Laumann; Edson D Moreira; Alessandra H Rellini; Taylor Segraves
Journal:  J Sex Med       Date:  2010-04       Impact factor: 3.802

4.  Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Adriana Garzaniti; Gabriele Pelissero; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Colomba Falcone; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-08-23       Impact factor: 3.633

5.  The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.

Authors:  Bhanu P Gupta; M Hassan Murad; Marisa M Clifton; Larry Prokop; Ajay Nehra; Stephen L Kopecky
Journal:  Arch Intern Med       Date:  2011-09-12

Review 6.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.

Authors:  Piero Montorsi; Paolo M Ravagnani; Stefano Galli; Andrea Salonia; Alberto Briganti; José P Werba; Francesco Montorsi
Journal:  Eur Urol       Date:  2006-07-28       Impact factor: 20.096

7.  Relationship between erectile dysfunction and silent myocardial ischemia in type 2 diabetic patients with no known macrovascular complications.

Authors:  Katherine García-Malpartida; Rosario Mármol; Ana Jover; Manuel J Gómez-Martínez; Eva Solá-Izquierdo; Victor M Victor; Milagros Rocha; Darío Sanmiguel; Antonio Hernández-Mijares
Journal:  J Sex Med       Date:  2011-06-23       Impact factor: 3.802

Review 8.  Erectile dysfunction as a harbinger for increased cardiometabolic risk.

Authors:  K L Billups; A J Bank; H Padma-Nathan; S D Katz; R A Williams
Journal:  Int J Impot Res       Date:  2008-01-17       Impact factor: 2.896

9.  Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.

Authors:  Marina Jamnicki-Abegg; Dorothee Weihrauch; Pascal C Chiari; John G Krolikowski; Paul S Pagel; David C Warltier; Judy R Kersten
Journal:  J Cardiovasc Pharmacol       Date:  2007-12       Impact factor: 3.105

Review 10.  Review type 2 diabetes mellitus and erectile dysfunction.

Authors:  Josephine Hidalgo-Tamola; Kanchan Chitaley
Journal:  J Sex Med       Date:  2008-12-05       Impact factor: 3.802

View more
  11 in total

Review 1.  Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.

Authors:  Ângela Castela; Carla Costa
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

2.  Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Michela Petrizzo; Elisabetta Della Volpe; Rosanna Orlando; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2014-11-20       Impact factor: 3.633

3.  Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu.

Authors:  Istvan Kovanecz; Dolores Vernet; Maryam Masouminia; Robert Gelfand; Leila Loni; James Aboagye; James Tsao; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2016-05       Impact factor: 3.802

Review 4.  Endocrine evaluation of erectile dysfunction.

Authors:  Andrea Sansone; Francesco Romanelli; Daniele Gianfrilli; Andrea Lenzi
Journal:  Endocrine       Date:  2014-04-06       Impact factor: 3.633

5.  Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Arturo Pujia; Colomba Falcone; Silvia Collaviti; Mariangela Fodaro; Pietro Gallotti; Sebastiano B Solerte; Andrea Giustina; Gabriele Pelissero; Livio Luzi; Tiziana Montalcini
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

6.  Multiple PDE5Is use as a marker of decreased overall men's health: A real-life study.

Authors:  Davide Oreggia; Eugenio Ventimiglia; Paolo Capogrosso; Luca Boeri; Walter Cazzaniga; Filippo Pederzoli; Francesco Chierigo; Federico Dehò; Francesco Montorsi; Andrea Salonia
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

7.  Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China.

Authors:  Xiao-Na Pang; Yu Hu; Ying Yuan; Ji-Ping Shen; Xiao-Yun Zha; Xuan Sun
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

Review 8.  Is erectile dysfunction a reliable indicator of general health status in men?

Authors:  Andrea Salonia; Paolo Capogrosso; Maria Chiara Clementi; Giulia Castagna; Rocco Damiano; Francesco Montorsi
Journal:  Arab J Urol       Date:  2013-09-14

9.  Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes.

Authors:  Sara J Turek; Stephanie M Hastings; Jennifer K Sun; George L King; Hillary A Keenan
Journal:  Diabetes Care       Date:  2013-06-18       Impact factor: 19.112

10.  Relation Between Erectile Dysfunction and Silent Myocardial Ischemia in Diabetic Patients: A Multidetector Computed Tomographic Coronary Angiographic Study.

Authors:  Amr Abdelhamed; Shin-Ichi Hisasue; Essam A Nada; Ali M Kassem; Mohammed Abdel-Kareem; Shigeo Horie
Journal:  Sex Med       Date:  2016-06-30       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.